Physicians' Academy for Cardiovascular Education

ARNI as first-line therapy in de novo HFrEF patients after ADHF event

3' education - June 3, 2019

Educational information

This video was recorded at the ESC Heart Failure in Athens, Greece, on May 27, 2019 and is a reproduction of his presentation during the Rapid Fire 4 - Chronic heart failure - Pharmacology session.

Faculty

Michele Senni, MD, is cardiologist at the Hospital Papa Giovanni XXIII, Bergamo, Italy.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Read our summary of the subanalysis of the TRANSITION trial

Share this page with your colleagues and friends: